MedTrace Logo

Observatory on Cow's Milk Protein Allergy

NCT06085118 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-06-25

No results posted yet for this study

Summary

The purpose of this study is to describe the symptoms and their evolution up to the age of 5 years in a population of newly diagnosed infants with a suspected or confirmed allergy to cow proteins, for whom the doctor prescribed the Pepticate® Syneo® replacement formula as soon as they were diagnosed.

The Pepticate® Syneo® product is an advanced protein hydrolyzate, food type intended for special medical purposes. This is a product already available on the market.

Conditions

Interventions

OTHER

Pepticate® Syneo®

Introduction of the nutritional treatment Pepticate® Syneo® (high protein hydrolysate), as a foodstuff for special medical purposes (product already available on the market).

Sponsors & Collaborators

  • Nutricia Nutrition Clinique

    lead INDUSTRY

Eligibility

Max Age
8 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2031-11-30
Completion
2031-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06085118 on ClinicalTrials.gov